PDB74 - IDEGLIRA VERSUS IGLARLIXI FOR PATIENTS WITH INADEQUATELY CONTROLLED TYPE 2 DIABETES ON BASAL INSULIN- A LONG-TERM COST-EFFECTIVENESS ANALYSIS IN THE CZECH REPUBLIC

Oct 1, 2018, 00:00
10.1016/j.jval.2018.09.779
https://www.valueinhealthjournal.com/article/S1098-3015(18)34079-8/fulltext
Title : PDB74 - IDEGLIRA VERSUS IGLARLIXI FOR PATIENTS WITH INADEQUATELY CONTROLLED TYPE 2 DIABETES ON BASAL INSULIN- A LONG-TERM COST-EFFECTIVENESS ANALYSIS IN THE CZECH REPUBLIC
Citation : https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(18)34079-8&doi=10.1016/j.jval.2018.09.779
First page :
Section Title :
Open access? : No
Section Order : 178
Categories :
Tags :
Regions :
ViH Article Tags :